[{"address1": "19 Vestry Street", "city": "New York", "state": "NY", "zip": "10013", "country": "United States", "phone": "647 865 8622", "website": "https://brightmindsbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio of selective 5-HT receptor agonists includes 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry; and BMB-101 which completes phase 1 trial for undisclosed seizure disorder. The company also develops BMB-201 and BMB-202 for the treatment of neuropsychiatry and neurology indications. Bright Minds Biosciences Inc. has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. The company was founded in 2017 and is headquartered in New York, New York.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Ian  McDonald", "age": 36, "title": "Co-Founder, CEO, President & Director", "yearBorn": 1988, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ryan E. S. K. Cheung B.Com., CA, CPA", "age": 46, "title": "Chief Financial Officer", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 87138, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jan Torleif Pedersen M.Sc., Ph.D.", "age": 59, "title": "Chief Science Officer & Director", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 176672, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alex  Vasilkevich", "title": "COO & Senior Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Emer  Leahy M.B.A., Ph.D.", "age": 57, "title": "Consultant", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen D. Collins M.D., Ph.D.", "age": 71, "title": "Chief Medical Officer", "yearBorn": 1953, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 30.1, "open": 30.57, "dayLow": 29.59, "dayHigh": 31.36, "regularMarketPreviousClose": 30.1, "regularMarketOpen": 30.57, "regularMarketDayLow": 29.59, "regularMarketDayHigh": 31.36, "payoutRatio": 0.0, "beta": 1.192, "volume": 12908, "regularMarketVolume": 12908, "averageVolume": 38485, "averageVolume10days": 26580, "averageDailyVolume10Day": 26580, "bid": 30.58, "ask": 32.4, "bidSize": 1, "askSize": 1, "marketCap": 222505632, "fiftyTwoWeekLow": 0.931, "fiftyTwoWeekHigh": 79.02, "fiftyDayAverage": 33.3738, "twoHundredDayAverage": 26.6514, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 154310144, "forwardPE": -7.3356805, "profitMargins": 0.0, "floatShares": 2524284, "sharesOutstanding": 7043990, "sharesShort": 86922, "sharesShortPriorMonth": 108576, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.0123000005, "heldPercentInsiders": 0.22549, "heldPercentInstitutions": 0.78929, "shortRatio": 2.51, "shortPercentOfFloat": 0.018099999, "impliedSharesOutstanding": 7120180, "bookValue": 8.274, "priceToBook": 3.7768915, "lastFiscalYearEnd": 1727654400, "nextFiscalYearEnd": 1759190400, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -1068069, "trailingEps": -0.14, "lastSplitFactor": "1:5", "lastSplitDate": 1689292800, "52WeekChange": 26.239819, "SandP52WeekChange": 0.08001411, "quoteType": "EQUITY", "currentPrice": 31.25, "targetHighPrice": 92.4651, "targetLowPrice": 92.4651, "targetMeanPrice": 92.4651, "targetMedianPrice": 92.4651, "recommendationMean": 1.4, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 1, "totalCash": 57896664, "totalCashPerShare": 8.219, "totalDebt": 182733, "quickRatio": 125.592, "currentRatio": 126.151, "debtToEquity": 0.316, "returnOnAssets": -0.04926, "returnOnEquity": -0.03345, "freeCashflow": -1400343, "operatingCashflow": -2522493, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "CAD", "symbol": "DRUG", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Bright Minds Biosciences Inc.", "longName": "Bright Minds Biosciences Inc.", "regularMarketChangePercent": 3.8205967, "regularMarketPrice": 31.25, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1616419800000, "marketState": "REGULAR", "regularMarketChange": 1.1499996, "regularMarketDayRange": "29.59 - 31.36", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 38485, "fiftyTwoWeekLowChange": 30.319, "fiftyTwoWeekLowChangePercent": 32.56606, "fiftyTwoWeekRange": "0.931 - 79.02", "fiftyTwoWeekHighChange": -47.769997, "fiftyTwoWeekHighChangePercent": -0.60453045, "fiftyTwoWeekChangePercent": 2623.982, "epsTrailingTwelveMonths": -0.14, "epsCurrentYear": -1.916, "priceEpsCurrentYear": -16.31002, "fiftyDayAverageChange": -2.1237984, "fiftyDayAverageChangePercent": -0.0636367, "twoHundredDayAverageChange": 4.5986004, "twoHundredDayAverageChangePercent": 0.1725463, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-11-08", "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "corporateActions": [], "regularMarketTime": 1746719762, "exchange": "NCM", "messageBoardId": "finmb_691048918", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "Bright Minds Biosciences", "trailingPegRatio": null, "__fetch_time": "2025-05-08"}]